Medical devices, healthcare technology and the business of care
PMA approval · P050027

KARL STORZ PHOTODYNAMIC DIAGNOSTIC D-LIGHT C (PDD) SYSTEM

Karl Storz Endoscopy-America, Inc. · Decision date May 28, 2010

MEDTECHLEDGER EXPLANATIONP050027

What did the FDA approve?

The May 28, 2010 approval covers the KARL STORZ Photodynamic Diagnostic D-Light C (PDD) System, a diagnostic endoscopic light source system. The stated scope is use in combination with the optical imaging drug Cysview (hexaminolevulinate hydrochloride) for intravesical solution for photodynamic blue light cystoscopy, as an adjunct to white light cystoscopy.

The stated purpose is detection of non-muscle invasive papillary cancer of the bladder in patients suspected or known to have the lesion on the basis of a prior cystoscopy. The source statement reports an intended use; it does not independently establish safety or clinical effectiveness. No supplement type or reason is supplied.

FDA approval order statement

APPROVAL FOR THE KARL STORZPHOTODYNAMIC DIAGNOSTIC D-LIGHT C (PDD) SYSTEM. THE KARL STORZ PHOTODYNAMIC DIAGNOSTIC D-LIGHTC (PDD) SYSTEM IN COMBINATION WITH THE OPTICAL IMAGING DRUG CYSVIEW(HEXAMINOLEVULINATE HYDROCHLORIDE) FOR INTRAVESICAL SOLUTION IS INDICATED FOR PHOTODYNAMIC BLUELIGHT CYSTOSCOPY, AS AN ADJUNCT TO WHITE LIGHT CYSTOSCOPY FOR THE DETECTION OF NON-MUSCLE INVASIVEPAPILLARY CANCER OF THE BLADDER IN PATIENTS SUSPECTED OR KNOWN TO HAVE THE LESION ON THE BASIS OF A PRIOR CYSTOSCOPY.
Regulatory pathway
Original PMA
Clinical specialty
Gastroenterology, Urology
Decision date
May 28, 2010

FDA source record · MedtechLedger’s explanation describes the recorded change.

Regulatory record facts

Identifier
P050027
Regulatory pathway
Premarket approval application
Product code
OAY
Decision code
APPR
Decision date
May 28, 2010
Source update
Nov 9, 2026
Original record
Open FDA source record

About this medical device

FDA device category: Light source system, diagnostic endoscopic.

Product code
OAY
FDA device class
3

The approval statement above describes the scope recorded for this original decision. Later supplements may change the device or its indications.

FDA decision timeline

  1. P050027 received

    Application receipt date recorded by FDA.

  2. P050027 · FDA decision

    APPR

  3. P050027/S038 · Related supplement

    Photodynamic Diagnostic D-Light C System

Timeline entries are records held by MedtechLedger for P050027. View FDA’s full supplement list.

Related devices and submissions

Same PMA: P050027

Product / regulatory recordCompanyPathwayDecision dateSource
Karl Storz Endoscopy-America, Inc.PMA supplementOct 14, 2026FDA

Explore the linked device profile

Regulatory context

An original PMA is a premarket approval application. The recorded approval scope is described in FDA’s order and supporting documents.

Read our guide to FDA clearance and approval · FDA’s explanation of this pathway

Manufacturer intelligence

Karl Storz Endoscopy-America, Inc.

Headquarters
Not reported
Brand website
Not reported
FDA applicant address
2151 E. Grand Ave., El Segundo, CA, 90245

Sources and methodology

FDA fields and approval-order wording are presented as source information. MedtechLedger explanations are identified separately and describe the scope of the recorded decision. Indications from an original PMA are historical unless confirmed against subsequent labeling and supplements.

How we use FDA records